NCT05042817View on ClinicalTrials.gov

Effect of Intrathecal Morphine on Urinary Bladder Function and Recovery in Patients Having a Cesarean Delivery

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

December 31, 2022

Conditions
Analgesia
Interventions
DRUG

100 mcg morphine

The effect of intrathecal morphine on vesical function and the need for bladder re-catheterization after a cesarean delivery

DRUG

0.9% NaCl

NaCl 0.9%

DRUG

50 mg prilocaine + 2.5 mcg sufentanil

50 mg prilocaine + 2.5 mcg sufentanil

PROCEDURE

bilateral transverse abdominal plane block

20 mL of ropicavaine 0.375% on each side

Trial Locations (1)

4000

University of Liege, University Hospital, Liège

All Listed Sponsors
lead

University of Liege

OTHER

NCT05042817 - Effect of Intrathecal Morphine on Urinary Bladder Function and Recovery in Patients Having a Cesarean Delivery | Biotech Hunter | Biotech Hunter